Search 

Oncimmune, a global leader in immunodiagnostics and (auto) antibody biomarker profiling & discovery in immuno-oncology, autoimmune and infectious diseases. Through its ImmunoINSIGHTS™ technology platform, the company provides insights to discover and validate novel biomarkers, improve treatment responses and adverse event (irAE) prediction, patient screening and diagnostic accuracy. Oncimmune is headquartered in the UK with operations in Germany and USA.

Oppilotech is a science-driven company founded by a group of friends with the shared ambition to improve human health. The founding team: Ajay, John, Cora, Tony and Keith; have many years of experience working in Pharma, Biotech and academia spanning fundamental R&D, drug discovery, business development, investment and IP management.

Our unique blend of skills combined with a love of science have made Oppilotech an exciting, dynamic, flexible and collaborative company.